|
Variable
|
Number
|
Percent or SD
|
|---|
|
Female
|
7,639
|
67.4
|
|
Age in years at cohort entry
|
65.3
|
14.5
|
|
Recipient of social assistance at cohort entrya
|
939
|
8.3
|
|
Urban residencea
|
8,884
|
78.4
|
|
High healthcare use at baseline
|
2981
|
26.3
|
|
Prior joint replacement
|
352
|
3.14
|
|
Comorbidities
| | |
|
Myocardial infarction
|
291
|
2.6
|
|
Diabetes
|
1,668
|
14.7
|
|
Osteoporosis
|
1,722
|
15.2
|
|
Cerebrovascular disease
|
54
|
0.48
|
|
Acute renal failure
|
314
|
2.8
|
|
Chronic renal failure
|
298
|
2.6
|
|
Coronary artery disease
|
1,952
|
17.2
|
|
COPD-asthma
|
2,587
|
22.8
|
|
Any type of cancer
|
1,326
|
11.7
|
|
Osteoarthritis
|
3,469
|
30.6
|
|
Charlson comorbidity
|
1.2
|
1.9
|
|
Drug use prior to cohort entry
| | |
|
GC
|
4,360
|
38.5
|
|
COXIBs
|
4,824
|
42.6
|
|
NSAIDs
|
4,491
|
39.6
|
-
COPD chronic obstructive pulmonary disease, GC glucocorticoids, COXIBs cyclooxygenase-2 inhibitors, NSAIDs nonselective nonsteroidal anti-inflammatory drugs
-
aDefined by census tract data
